Yoshihiro Mezawa

Years Active: 2019-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Yoshihiro Mezawa, Tingwei Wang, Yataro Daigo, Atsushi Takano, Yohei Miyagi, Tomoyuki Yokose, Toshinari Yamashita, Liying Yang, Reo Maruyama, Hiroyuki Seimiya, Akira Orimo
Glutamine deficiency drives transforming growth factor-β signaling activation that gives rise to myofibroblastic carcinoma-associated fibroblasts. Cancer science (2023)
Yu Koyama, Hiroya Okazaki, Yang Shi, Yoshihiro Mezawa, Zixu Wang, Mizuki Sakimoto, Akane Ishizuka, Yasuhiko Ito, Takumi Koyama, Yataro Daigo, Atsushi Takano, Yohei Miyagi, Tomoyuki Yokose, Toshinari Yamashita, Keisuke Sugahara, Okio Hino, Liying Yang, Reo Maruyama, Akira Katakura, Takehiro Yasukawa, Akira Orimo
Increased RUNX3 expression mediates tumor-promoting ability of human breast cancer-associated fibroblasts. Cancer medicine (2023)
Yoshihiro Mezawa, Akira Orimo
Phenotypic heterogeneity, stability and plasticity in tumor-promoting carcinoma-associated fibroblasts. The FEBS journal (2021)
Yoshihiro Mezawa, Yataro Daigo, Atsushi Takano, Yohei Miyagi, Tomoyuki Yokose, Toshinari Yamashita, Chikao Morimoto, Okio Hino, Akira Orimo
CD26 expression is attenuated by TGF-β and SDF-1 autocrine signaling on stromal myofibroblasts in human breast cancers. Cancer medicine 8 (8) (2019)

Yoshihiro Mezawa.css-eqlu8i{font-size:small;padding-left:4px;}